[{"id":"f1d332b1-f3f4-4a32-8d46-6706630bf71c","acronym":"","url":"https://clinicaltrials.gov/study/NCT05150457","created_at":"2021-12-09T18:00:08.963Z","updated_at":"2025-02-25T13:36:00.973Z","phase":"Phase 1","brief_title":"Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05150457","lead_sponsor":"Binacea Pharma, Inc.","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BNA035"],"overall_status":"Recruiting","enrollment":" Enrollment 48","initiation":"Initiation: 02/08/2022","start_date":" 02/08/2022","primary_txt":" Primary completion: 11/01/2023","primary_completion_date":" 11/01/2023","study_txt":" Completion: 11/01/2025","study_completion_date":" 11/01/2025","last_update_posted":"2022-09-27"}]